MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00345-014-1239-z

Медицинская библиотека · World journal of urology · 2014

Efficacy of silodosin in patients undergoing brachytherapy: a randomized trial involving a pressure flow study.

Shimizu Nobutaka, Minami Takafumi, Sugimoto Koichi, Saito Yoshitaka, Yamamoto Yutaka, Hayashi Taiji, Tsuji Hidenori, Nozawa Masahiro, Yoshimura Kazuhiro, Ishii Tokumi, Uemura Hirotsugu, Nakamatsu Kiyoshi

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

PURPOSE: The purpose of the study is to investigate the efficacy of an alpha-1 adrenergic receptor antagonist (silodosin) for the treatment of lower urinary tract symptoms (LUTS) associated with interstitial (125)I implantation for prostate cancer.

METHODS

This randomized single-center study involved 105 patients (53 with and 52 without silodosin). Silodosin was postoperatively administered, daily, for 6 months (8 mg/day). Urinary symptoms and pressure flow were evaluated preoperatively and postoperatively at 1, 3, 6, and 12 months.

RESULTS

At 12 months, interstitial (125)I implantation had induced a significant decrease in prostate volume (28.3 ± 11.1-20.5 ± 8.1 g in the silodosin group and 26.1 ± 9.7-17.7 ± 4.9 g in the controls) and the prostate-specific antigen level (7.1 ± 3.6-1.4 ± 1.7 ng/mL in the silodosin group and 8.1 ± 4.3-1.3 ± 1.2 ng/mL in the controls). Significant improvements in the international prostate symptom voiding subscores at 6 months and quality of life at 3 months were observed in those receiving silodosin. The pressure flow studies demonstrated that silodosin had significantly enlarged the bladder capacity when the first non-voiding contraction was seen at 3 and 12 months (3M: 127.1 ± 74.8 vs. 118.2 ± 83.9 mL, p = 0.001; 12M: 123.7 ± 79.3 vs. 100.3 ± 73.4 mL, p = 0.01); however, there were no improvements in the bladder outlet obstruction index (BOOI) or urinary flow.

CONCLUSIONS

Silodosin temporarily improved LUTS, but did not improve the BOOI after (125)I implantation in the prostate.

Для цитирования: Shimizu Nobutaka, Minami Takafumi, Sugimoto Koichi, Saito Yoshitaka, Yamamoto Yutaka, Hayashi Taiji, Tsuji Hidenori, Nozawa Masahiro, Yoshimura Kazuhiro, Ishii Tokumi, Uemura Hirotsugu, Nakamatsu Kiyoshi. Efficacy of silodosin in patients undergoing brachytherapy: a randomized trial involving a pressure flow study.. World journal of urology. 2014. DOI: 10.1007/s00345-014-1239-z.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.